Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Study of Bortezomib in Combination With Melphalan and Prednisone for Patients With Previously Untreated Multiple Myeloma

NCT00734149 is registered in ClinicalTrials.gov with Duke University as lead sponsor.

NCT NCT00734149
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00734149 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Study of Bortezomib in Combination With Melphalan and Prednisone for Patients With Previously Untreated Multiple Myeloma
Lead sponsor
Duke University
Phase
Phase 2
Overall status
Completed
Start date
July 31, 2004
Completion date
February 29, 2008
Enrollment
45 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

multiple myeloma